April is National Minority Cancer Awareness Month. Igualar el acceso a la prevención, detección y tratamiento del cáncer de pulmón. Puede descargar materiales en español sobre la prevención y el tratamiento del cáncer de pulmón. LCRF.org/conozca

#LungCancer #CancerDePulmon

Researchers find way to treat lung cancer and associated muscle wasting at the same time | Newsroom PORTLAND, Ore. – Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it. The study,…

Oregon State University researchers have made a compelling dual-target discovery. They have developed a single therapy that simultaneously targets lung cancer and cancer cachexia. #lungcancer
news.oregonstate.edu/news/researc...

"Lung-MAP is the most transformative & pivotal trial in the MET Crusaders right now."
Hear MET Crusaders Chair Marcia K. Horn, JD, on 3 Lung-MAP studies for patients with advanced non-small cell #lungcancer with MET biomarkers. #lcsm #ClinicalTrials @focr.bsky.social
www.youtube.com/watch?v=H1mx...

Dosimetric Performance Analysis of Pediatric Based Halcyon™ Volumetric Arc Therapy-Based Lung-Sparing Total Body Irradiation
@tcrtcancer.bsky.social
@journals.sagepub.com
@upenn.edu

journals.sagepub.com/doi/10.1177/...

#cancertreatment #radiationtherapy #oncology #lungcancer #openaccess

EGFR Biology and Treatment Selection Beyond PD-L1 in EGFR-Mutated NSCLC | CancerNetwork In this segment, Alexander Spira, MD, PhD, engages Natalie Vokes, MD, in a discussion on the distinct biology of EGFR-mutated non–small cell lung cancer and how it informs treatment decisions in the…

EGFR-mutated NSCLC is not just another subtype of lung cancer — it is a distinct molecular entity that demands a fundamentally different treatment strategy. #lungcancer
www.cancernetwork.com/view/egfr-bi...

First-line targeted therapy shows antitumor activity in patients with advanced lung cancer First-line zongertinib showed antitumor activity in treatment-naïve patients with advanced or metastatic HER2-mutant non-small cell lung cancer (NSCLC), providing a safe and effective oral targeted tr...

A promising #targetedtherapy is showing real first-line activity in advanced HER2-mutant lung cancer. MD Anderson reports zongertinib delivered strong anti tumour results, offering a potential oral alternative to chemo for patients. #LungCancer #Oncology #TCSC
www.mdanderson.org/newsroom/res...

Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer

Engineered NR3C1-deleted CAR-NK cells bypass cortisol-mediated suppression restoring PI3K-AKT-NF-κB signaling and #Cytotoxicity to overcome steroid-induced #Immunosuppression and enhance tumor control in #LungCancer.
#STTT #OpenAccess: doi.org/10.1038/s413...

Thank you to #ClevelandClinic for hosting this important symposium on early #lungcancer detection and inviting our Dr. Downie to participate in a panel on the evolving landscape of pulmonary lung nodule management.
#CyPathLung #LungCancerAwareness #Pulmonology #EarlyDetection

Altered Sphingolipid Metabolism is Associated with Osimertinib Resistance in Nonsmall-Cell Lung Cancer Nonsmall-cell lung cancer (NSCLC) accounts for more than 80% of lung cancer cases. Epidermal growth factor receptor mutations (EGFRm) occur in 15 and 40% of NSCLC in Western and Asian populations, res...

Find out how #lipid #metabolism plays a role in #drugresistance in #lungcancer in our new study from the PhD work of Julia Babuta and collaboration with AstraZeneca!

pubs.acs.org/doi/full/10....

Congratulations to Drs. Ilana Richman and Lynn Tanoue, recipients of grant funding from the #NCCN Oncology Research Program (ORP) for their project, "A Multilevel Intervention to Support Retention in Annual #LungCancer Screening."

Quote from JAMA, "I thought I was healthy—a lifelong nonsmoker. A wife and mother of 3. A psychiatrist and residency program director who loves her patients and her residents. And then I was diagnosed with lung cancer." - A Piece of My Mind, Jenna Taglienti, MD

"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life."

In #APieceofMyMind, a psychiatrist and residency program director reflects on an unexpected #LungCancer diagnosis.

ja.ma/3Qre9ZU

April is National Minority Cancer Awareness Month. It's a time to raise awareness about the disparities that impact minority communities and the importance of early detection, education, and equitable care. #LungCancer #NMCAM #MCAM

JAMA Surgery info shows: American College of Surgeons to Enhance Lung Cancer Surgical Quality. Objective: Increase compliance. Methods: 354 Commission on Cancer accredited hospitals and 18,513 lung cancer resections. Outcomes: Programs 144@0 -> 238@1.

Participation in the Lung NODES National Quality Improvement Collaborative improved hospital-level compliance with lymph node sampling during #LungCancer surgery, with a median compliance increase from 67.8% to 90.5% across diverse program types. ja.ma/4sH2jIC

Lung Cancer Questions to Ask Your Doctor - GO2 for Lung Cancer Prepare for your appointments by knowing the important lung cancer questions to ask your doctor and healthcare team. Get your list of questions with GO2.

There’s a lot to process after a #LungCancer diagnosis.

Between appointments, information, and emotions, it can be hard to know what questions to ask your care team.

We’re here to help you feel prepared, every step of the way.
🔗: go2.org/lung-cancer-...

New AI tool predicts whether aggressive small cell lung cancer will respond to treatment Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based…

Researchers at Roswell Park Comprehensive Cancer Center and Winship Cancer Institute of Emory University have developed an AI-powered tool that can predict treatment response in extensive-stage small cell lung cancer before a single dose of chemotherapy is given. #lungcancer

First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

www.nejm.org/doi/full/10....

Zongertinib, a selective HER2-targeted tyrosine kinase inhibitor, was evaluated as first-line therapy in advanced HER2-mutant #NSCLC 🫁 . #LungCancer

Unpacking the Advantages and Limitations of Leading Frontline Regimens in EGFR-Mutated NSCLC | OncLive Susan Scott, MD, Julia Rotow, MD, and Enriqueta Felip, MD, PhD, debate the optimal choice of frontline regimen for EGFR-mutated NSCLC.

🧬 From osimertinib monotherapy to osimertinib + chemo and emerging regimens like amivantamab + lazertinib, clinicians now face key trade-offs in efficacy, toxicity, and sequencing.
Read more ➡️ www.onclive.com/view/unpacki...
#LungCancer #NSCLC #PrecisionOncology #TargetedTherapy #Oncology

A blood test is detecting combined small cell #lungcancer (cSCLC) at 3x the rate of standard biopsy.

cSCLC is rarer & deadlier than standard SCLC - a mix of 2 cancer types in 1 tumour. ~14% of patients labelled as standard SCLC have it & are being treated wrong.

www.cell.com/cell-reports... #LCSM

Kudos to Aultman Health Foundation for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study

Mount Sinai Study Finds Lung Cancer Surgery Safe for Many Patients Over 80 Left to right: Emanuela Taioli, MD, PhD; Raja M. Flores,MD; Claudia Henschke, PhD, MD; and David F. Yankelevitz, MD.

New research is challenging the idea of how old is too old for surgery in early-stage lung cancer. #lungcancer
www.mountsinai.org/about/newsro...

RCPA Fellows A/Prof Caroline Cooper and Dr Jennifer Borowsky will be joining this @togaanz.bsky.social webinar to help oncologists and care teams to confidently interpret #lungcancer #molecularpathology reports. Pathologists are also welcome to explore opportunities for greater collaboration!

Her Dad Smoked. His Mom Never Did. Both Got Lung Cancer.

#GGRClips #GreaterGoodRadio #ConnectLearnHealGrow #SherryMenor #Grief #LungCancer

WATCH the FULL VIDEO 👉 https://youtu.be/V65nl-YOOdQ

LCRF grants Team Science Award focused on curing EGFR-Mutant Lung Cancers - Lung Cancer Research Foundation Teams led by Kwok-Kin Wong, MD, PhD and Matthew Meyerson, MD, PhD receive $1.5 million grant NEW YORK, NY (April 14, 2026) – The Lung Cancer Research Foundation (LCRF) announces […]

Work led by Drs. Kwok-Kin Wong and Matthew Meyerson was chosen to receive the LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers, made possible by a generous private donation. Read more about the research: LCRF.org85d511

#LungCancer #EGFR

Targeted Therapy Improves Long-Term Outcomes for Patients with Rare Mutations Driving Lung Cancer | Mass General Brigham Mass General Brigham Cancer Institute study found that patients with advanced RET fusion-positive lung cancer showed robust and durable responses.

Congrats to the researchers at the ALCMI consortium member, Mass General Brigham Cancer Institute. They have shown that pralsetinib can extend median overall survival for advanced RET fusion-positive NSCLC from roughly 4–11 months to 44 months. #lungcancer
www.massgeneralbrigham.org/en/about/new...

Mike Bossy takes leave of absence to receive treatment for lung

On April 14th, 2022: #MikeBossy, Canadian Hockey HOF right wing (Stanley Cup 1980-83; Conn Smythe Trophy 1982; 7 x NHL All Star; NY Islanders), died of #lungcancer at 65.
#RIP 🕊️🤍

#Lungcancer spreads to the brain more than almost any other cancer.

For many people living with it, that’s one of the most feared complications & until recently, one of the least understood.

A 🆕 review just published in Science Signaling sets out what science is now beginning to understand. #LCSM

Population-level lung cancer rate higher than NLST rate Researchers reported a higher lung cancer detection rate after a shorter follow-up period.

Researchers reported a lung cancer diagnosis rate of 4% in a large regional community health care system in the Mississippi Delta #radiology #lungcancer

Report: 2026 cancer rates to remain high in Canada The findings underscore the need for caregivers to stay informed regarding incidence of the disease.

Cancer rates in Canada for 2026 are projected to remain high, particularly for lung, breast, prostate, and colorectal cancers -- which will likely make up 47% of new diagnoses #radiology #prostatecancer #breastcancer #colorectalcancer #lungcancer buff.ly/Hnu9YyM

The April 2026 issue of The Lancet Regional Health - Americas is now available online!

lnkd.in/gcRM-wYU
In this issue: #USDietaryGuidelines, #NosocomialInfections, #LongCOVID, #OropoucheVirus, #RenalCellCarcinoma, #ColorectalCancer, #LungCancer, #YellowFever, #OpioidUseDisorder, and much more.

Estela Rodriguez: Fred R. Hirsch on the Past, Present, and Future of Lung Cancer Precision Oncology - OncoDaily Estela Rodriguez: Fred R. Hirsch on the Past, Present, and Future of Lung Cancer Precision Oncology / cancer, Estela Rodriguez, Fred R. Hirsch, Lung cancer,

Fred R. Hirsch on the Past, Present, and Future of Lung Cancer Precision Oncology - Estelamari Rodriguez

@latinamd.bsky.social

oncodaily.com/voices/estel...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer